Cleared Traditional

K925701 - MINIPACK 911-STC

K925701 is an FDA 510(k) clearance for MINIPACK 911-STC, manufactured by Pace Tech, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 637-day FDA review.

K925701 · Pace Tech, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1994
Decision
637d
Days
Class 2
Risk

K925701 is an FDA 510(k) clearance for the MINIPACK 911-STC. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Pace Tech, Inc. (Clearwater, US). The FDA issued a Cleared decision on August 11, 1994 after a review of 637 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Pace Tech, Inc. devices

FDA 510(k) Submission Details - K925701

510(k) Number K925701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 1992
Decision Date August 11, 1994
Days to Decision 637 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
497d slower than avg
Panel avg: 140d · This submission: 637d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 192
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K925701.
9100 MUTIGAS MONITOR
K941971 · Bci Intl., Inc. · Nov 1994
COMET CAPNOGRAPH MODULE
K941165 · Spacelabs, Inc. · Oct 1994
PEDI-CAP
K944400 · Nellcor, Inc. · Sep 1994
AS/3(TM) ANESTHESIA MONITOR SYST INTERFACE BOARD
K935477 · Datex Division Instrumentarium Corp. · Aug 1994
AS/3 TM NETWORK
K933284 · Datex Division Instrumentarium Corp. · Jul 1994
MASS SPECTROMETRY MONITORING LINES AND CONNECTORS
K942567 · Med-Plastics Intl., Inc. · Jun 1994